CID 169502193

Sildenafil metabolite m10

Structural Information

Molecular Formula
C21H28N6O5S
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCNC(C4)O)OCC)C
InChI
InChI=1S/C21H28N6O5S/c1-4-6-15-18-19(26(3)25-15)21(29)24-20(23-18)14-11-13(7-8-16(14)32-5-2)33(30,31)27-10-9-22-17(28)12-27/h7-8,11,17,22,28H,4-6,9-10,12H2,1-3H3,(H,23,24,29)
InChIKey
WDKKVIGLJAHWAC-UHFFFAOYSA-N
Compound name
5-[2-ethoxy-5-(3-hydroxypiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

476.1842 Da
Monoisotopic Mass

0.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 477.191476 216.1
[M+Na]+ 499.173418 224.9
[M-H]- 475.176924 216.4
[M+NH4]+ 494.218023 217.4
[M+K]+ 515.147358 216.7
[M+H-H2O]+ 459.181460 206.8
[M+HCOO]- 521.182401 219.5
[M+CH3COO]- 535.198051 228.6
[M+Na-2H]- 497.158866 214.1
[M]+ 476.18365142 218.6
[M]- 476.18474858 218.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.